期刊论文

Post Stroke Patients with Anxiety Disorder and Heart and Spleen Deficiency Syndrome Treated with Jiuwei Zhenxin Granules Observation on 60 Cases

中文

中医杂志

Journal of Traditional Chinese Medicine

1001-1668

2015

56

4

323-326

10.13288/j.11-2166/r.2015.04.015

本校为其他机构

目的观察九味镇心颗粒治疗脑卒中后焦虑性障碍的临床疗效。方法将120例心脾两虚证的脑卒中后焦虑性障碍患者随机分为治疗组和对照组各60例,治疗组口服九味镇心颗粒,每次6 g,每日3次;对照组口服氢溴酸西酞普兰片,每次20 mg,每日1次,两组均治疗6周。观察治疗前及治疗后1、2、4、6周汉密尔顿焦虑量表(HAMA)总分及其精神性焦虑与躯体性焦虑因子评分,同时进行临床疗效总评量表(CGI)、中国脑卒中临床神经功能缺损程度评分表(CSS)评分,治疗后评价临床疗效。结果治疗组临床疗效总有效率为80.67%,对照组为91.67%,两组比较差异无统计学意义(P>0.05)。两组患者治疗后4、6周HAMA、CGI、CSS评分均显著改善(P

Objective To observe the clinical efficacy of Jiuwei Zhenxin Granules in the treatment of post stroke anxiety disorder with heart and spleen deficiency syndrome. Methods In total 120 patients were randomly assigned to treatment group and control group,with 60 in each. The treatment group took Jiuwei Zhenxin Granules,6 g each time,three times daily,while the control group took citalopram tablets,20 mg each time,four times a day,for 6weeks. The scores of Hamilton Anxiety Scale（ HAMA）,Clinical Global Impression Scale（ CGI）,Chinese Stroke Neuro...